Pharmaceutical Injection

Product Details:

Ozempic (Semaglutide 0.5mg) is an injectable prescription medicine used:
along with diet and exercise to improve blood sugar in adults with type 2 diabetes.to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes with known heart disease.It is not known if Ozempic can be used in people who have had pancreatitis.Ozempic is not a substitute for insulin and is not for use in people with type 1 diabetes or people with diabetic ketoacidosis.It is not known if Ozempic is safe and effective for use in children under 18 years of age.
Skip to main contentImportant Safety InformationDo not share your Ozempic pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
What is the most important information I should know about Ozempic?
Ozempic may cause serious side effects, including:
Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic and medicines that work like Ozempic caused thyroid tumors, including thyroid cancer. It is not known if Ozempic will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.Do not use Ozempic if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).Do not use Ozempic if:you or any of your family have ever had MTC or if you have MEN 2.you are allergic to semaglutide or any of the ingredients in Ozempic.Before using Ozempic, tell your health care provider if you have any other medical conditions, including if you:have or have had problems with your pancreas or kidneys.have a history of diabetic retinopathy.are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if Ozempic will harm your unborn baby or passes into your breast milk. You should stop using Ozempic 2 months before you plan to become pregnant.Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
What are the possible side effects of Ozempic?
Ozempic may cause serious side effects, including:
inflammation of your pancreas (pancreatitis). Stop using Ozempic and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic.low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.serious allergic reactions. Stop using Ozempic and get medical help right away if you have any symptoms of a serious allergic reaction, including itching, rash, or difficulty breathing.

Additional Information:

• Item Code: NA2
• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

BEOVU (brolucizumab-dbll 6mg) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD). Important Safety Information Contraindications Beovu is contraindicated in patients with ocular or periocular infections, active intraocular inflammation or known hypersensitivity to brolucizumab or any of the excipients in BEOVU. Hypersensitivity reactions may manifest as rash, pruritus, urticaria, erythema, or severe intraocular inflammation. WARNINGS AND PRECAUTIONS Endophthalmitis and Retinal Detachment Intravitreal injections, including those with BEOVU, have been associated with endophthalmitis and retinal detachment. Proper aseptic injection techniques must always be used when administering BEOVU. Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay and should be managed appropriately. Retinal Vasculitis and/or Retinal Vascular Occlusion Retinal vasculitis and/or retinal vascular occlusion, typically in the presence of intraocular inflammation, have been reported with the use of BEOVU. Patients should be instructed to report any change in vision without delay. Increase in Intraocular Pressure Acute increases in intraocular pressure (IOP) have been seen within 30 minutes of intravitreal injection including with BEOVU. Sustained IOP increases have also been reported. Both IOP and perfusion of the optic nerve head must be monitored and managed appropriately. Thromboembolic Events Although there was a low rate of arterial thromboembolic events (ATEs) observed in the BEOVU clinical trials, there is a potential risk of ATEs following intravitreal use of VEGF inhibitors. Arterial thromboembolic events are defined as nonfatal stroke, nonfatal myocardial infarction, or vascular death (including deaths of unknown cause). The ATE rate in the two controlled 96-week neovascular AMD studies (HAWK and HARRIER) during the first 96-weeks was 4.5% (33 of 730) in the pooled brolucizumab arms compared with 4.7% (34 of 729) in the pooled aflibercept arms. ADVERSE REACTIONS Serious adverse reactions including endophthalmitis, retinal detachment, retinal vasculitis and/or retinal vascular occlusion, increases in intraocular pressure, and arterial thromboembolic events have occurred following intravitreal injections with BEOVU. The most common adverse events (≥5% of patients) with BEOVU were vision blurred, cataract, conjunctival hemorrhage, vitreous floaters and eye pain. As with all therapeutic proteins, there is a potential for an immune response in patients treated with BEOVU. Anti-brolucizumab antibodies were detected in the pre-treatment sample of 36% to 52% of treatment naive patients. After initiation of dosing, anti-brolucizumab antibodies were detected in at least one serum sample in 53% to 67% of patients treated with BEOVU. Intraocular inflammation was observed in 6% of patients with anti-brolucizumab antibodies detected during dosing with BEOVU. The significance of anti-brolucizumab antibodies on the clinical effectiveness and safety of BEOVU is not known.

Product Details:

TECENTRIQ (Atezolizumab 1200mg) is a prescription medicine used to treat adults with: A type of bladder and urinary tract cancer called urothelial carcinoma. What is the most important information about TECENTRIQ? TECENTRIQ can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during your treatment or even after your treatment has ended. Call or see your healthcare provider right away if you develop any new or worse signs or symptoms, including: Lung problems cough shortness of breath chest pain Intestinal problems diarrhea (loose stools) or more frequent bowel movements than usual stools that are black, tarry, sticky, or have blood or mucus severe stomach-area (abdomen) pain or tenderness Liver problems yellowing of your skin or the whites of your eyes severe nausea or vomiting pain on the right side of your stomach area (abdomen) dark urine (tea colored) bleeding or bruising more easily than normal Hormone gland problems headaches that will not go away or unusual headaches eye sensitivity to light eye problems rapid heartbeat increased sweating extreme tiredness weight gain or weight loss feeling more hungry or thirsty than usual urinating more often than usual hair loss feeling cold constipation your voice gets deeper dizziness or fainting changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness Kidney problems decrease in your amount of urine blood in your urine swelling of your ankles loss of appetite Skin problems rash itching skin blistering or peeling painful sores or ulcers in mouth or nose, throat, or genital area fever or flu-like symptoms swollen lymph nodes Problems can also happen in other organs. These are not all of the signs and symptoms of immune system problems that can happen with TECENTRIQ. Call or see your healthcare provider right away for any new or worse signs or symptoms, including: Chest pain, irregular heartbeat, shortness of breath, or swelling of ankles Confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs Double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight Persistent or severe muscle pain or weakness, muscle cramps Low red blood cells, bruising Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: chills or shaking itching or rash flushing shortness of breath or wheezing dizziness feeling like passing out fever back or neck pain Complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with TECENTRIQ. Your healthcare provider will monitor you for these complications. Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with TECENTRIQ. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with TECENTRIQ if you have severe side effects.

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

Nebido is a testosterone preparation for intramuscular injection. One ampoule contains 1,000 mg testosterone undecanoate in 4 mL oily vehicle (castor oil). The shelf life of Nebido is 5 years. Nebido is the first long-acting testosterone injection for the treatment of male hypogonadism. Nebido contains 1,000 mg of testosterone undecanoate in a 4 mL oily solution in an innovative formulation which offers a superior kinetic profile. After administration of Nebido, testosterone levels remain within the physiological range for about 12 weeks. Therefore, only 4 injections per year are required in long-term testosterone therapy. Nebido avoids unphysiological peaks and troughs in serum testosterone. It has been established in clinical studies that testosterone levels are already back to the normal range 3 days after the first administration of Nebido. On testosterone concentrations in the blood Pharmacokinetic studies have demonstrated that testosterone levels are restored to the physiological range within 3 days after the first administration of Nebido. With an interval between injections of about 12 weeks, testosterone concentrations remain constantly within the physiological range. The first dosing interval may be reduced to six weeks, which enables steady state testosterone levels to be achieved more rapidly. On clinical symptoms Nebido improves the symptoms associated with testosterone deficiency. Nebido exerts a positive effect on sexual function and mood, increases muscle mass and muscle strength and decreases body fat. The most frequent side effects observed with Nebido are reactions at the injection site. These reactions are generally mild and transient. All other side effects observed in isolated cases are typical of testosterone (such as diarrhoea, joint pain, sweating, headache, acne, chest pain and gynaecomastia). Pulmonary oil microembolism has been observed after injection during routine clinical practice and in rare cases lead to signs and symptoms such as cough, dyspnea, malaise, hyperhidrosis, chest pain, dizziness, paraesthesia, or syncope. These reactions may occur during or immediately after the injection and are reversible. The patient should therefore be observed during and immediately after each injection in order to allow for early recognition of possible signs and symptoms of pulmonary oily microembolism. Treatment is usually supportive, e.g. by administration of supplemental oxygen. Attention should be paid to the following recommendations for dosage: First and second administration of Nebido 6 weeks apart. Subsequently, depending on the needs of the individual patient, an interval of about 12 weeks is recommended. The first interval between injections may also be shortened to six weeks for patients who have switched from other testosterone preparations to Nebido, under observation of clinical symptoms. Ideally one ampoule of Nebido is injected deeply into the gluteal muscle slowly over a period of approximately 2 minutes. Measurement of serum trough testosterone levels and clinical symptoms should be considered for individualization of therapy with Nebido. Serum trough testosterone levels should be in the lower third of the normal range. Since steady state serum testosterone levels can be assumed to be achieved after the first six months of treatment, it appears advisable to control serum testosterone before the fourth injection (usual spacing between administrations provided).

Additional Information:

• Production Capacity: NA
• Packaging Details: "Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark."

Product Details:

Picasa (Posaconazloe 300mg) Injection belongs to a group of medicines called antifungals. It works by stopping the growth of fungus and is used to treat fungal infections. It kills fungi by destroying the fungal cell membrane. Do not self-administer this medicine. Your doctor or nurse will teach you the correct way of injecting it. To get the most benefit, take this medicine at evenly spaced times and continue using it until your prescription is finished, even if your symptoms disappear after a few days. If you stop treatment too early, the infection may return and if you miss doses you can increase your risk of infections that are resistant to further treatment. The most common side effects of this medicine include diarrhea, nausea, fever, vomiting, headache, coughing, and hypokalemia. These are not usually serious, but you should call your doctor if you think you might have a severe allergic reaction and signs of liver problems such as yellowing of eyes, dark urine, and stomach problems. Get emergency help if this happens. Do not take it if you are pregnant or could become pregnant unless your doctor has told you to. Talk to your doctor before taking it if you have ever had heart failure, kidney problems, or liver problems such as yellow skin (jaundice). This medicine may not be suitable for you. If your course of treatment is for more than a month, your doctor may want to check your liver, and potassium level by testing your blood. This medicine may make you dizzy or have blurred vision so do not drive or operate machines until it is safe. USES OF PICASA INJECTION Severe fungal infections BENEFITS OF PICASA INJECTION In Severe fungal infections Picasa 300mg Injection is an antifungal medicine. It works by killing and stopping the growth of fungus that is causing the infection. It helps treat severe infections in severely immunocompromised patients, cancer patients, and those undergoing blood transfusion. It is given as an injection by your doctor or healthcare provider and should not be self-administered. The dose and duration of treatment will depend on what you are being treated for. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning. SIDE EFFECTS OF PICASA INJECTION Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Picasa Diarrhea Nausea Fever Vomiting Headache Cough Decreased potassium level in blood HOW TO USE PICASA INJECTION Your doctor or nurse will give you this medicine. Kindly do not self administer. HOW PICASA INJECTION WORKS Picasa 300mg Injection is an antifungal medication. It kills fungi by destroying the fungal cell membrane. This treats your infection. SAFETY ADVICE warnings Alcohol CONSULT YOUR DOCTOR It is not known whether it is safe to consume alcohol with Picasa 300mg Injection. Please consult your doctor. warnings Pregnancy CONSULT YOUR DOCTOR Picasa 300mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. warnings Breastfeeding CONSULT YOUR DOCTOR Picasa 300mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. warnings Driving UNSAFE Picasa 300mg Injection may cause side effects which could affect your ability to drive. As you may feel dizzy, sleepy, or have blurred vision while taking Picasa 300mg Injection, which may affect your ability to drive.

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

Dexamethasone Injection is used to treat inflammation of the skin, joints, lungs, and other organs. Also Common conditions treated include asthma, allergies, and arthritis.td {border: 1px solid #ccc;}br {mso-data-placement:same-cell;}